|
Match
|
Document |
Document Title |
|
|
US20090311291 |
CONDOMS WITH LUBRICANT COMPOSITIONS AND PACKAGING PROVIDING ENHANCED FUNCTIONALITY
The present disclosure provides improved packaged condoms that enable the use of a large quantity of a composition inside the condom. In addition, a sufficient quantity of certain spermicidal...
|
|
|
US20090311354 |
COMPOSITION COMPRISING EXTRACTS OR FRACTIONS OF MAGNOLIA OBOVATA THUNB FOR TREATING AND PREVENTING INFLAMMATION DISEASE
The present invention relates to a composition for the prevention and treatment of inflammatory disease containing the extracts of Magnolia obovata or fractions thereof as an active ingredient,...
|
|
|
US20090304769 |
METHODS FOR IDENTIFYING AGENTS AND THEIR USE FOR THE PREVENTION OF RESTENOSIS
Agents that inhibit or prevent restenosis are identified by assaying test agents in a battery of assays to measure the effect of the test agent on cell proliferation, thrombosis, tissue modeling,...
|
|
|
US20090202633 |
Extended release formulations of guaifenesin
The present invention relates to extended release formulations comprising expectorant. More particularly, the present invention relates to extended release formulations comprising guaifenesin. The...
|
|
|
US20090203653 |
Compositions and Methods Using Apocynin Compounds and Nitric Oxide Donors
The invention describes novel compositions comprising at least one apocynin compound or a pharmaceutically acceptable salt thereof, and at least one nitric oxide donor, and, optionally, at least...
|
|
|
US20090155180 |
Methods and targets for identifying compounds for regulating rhinovirus infection
The present invention provides methods for identifying genes, expression regulators, receptors, protein product receptors, and proteins that may regulate rhinovirus infections. The genes identified...
|
|
|
US20090148426 |
COMPOSITION FOR LIFE EXTENSION AND METHOD OF EXTENDING THE LIFE
The present invention relates to a composition for life extension, comprising reduced coenzyme Q 10 as an active ingredient, as well as relates to a method of extending a life span using the...
|
|
|
US20090142425 |
Physiologically active composition
A physiologically active composition is claimed which comprises effective amounts of at least one compound from the group 4-O-methyldavidigenin, 4′-O-methyldavidigenin, davidigenin, elemicin,...
|
|
|
US20090143295 |
PEPTIDE-BASED ANTIACNE REAGENTS
Peptide-based antiacne reagents, formed by coupling a skin-binding peptide with an antiacne agent, are described. The skin-binding peptide portion of the peptide-based antiacne reagent binds...
|
|
|
US20090137687 |
Compositions and Methods With Enhanced Therapeutic Activity
This invention relates to novel tricyclic quinone and catechol compositions, compositions containing prodrugs of tricyclic quinone and catechol compositions, and methods of use for the treatment of...
|
|
|
US20090130159 |
WATER-DISPERSIBLE NANOPARTICLE CONTAINING MICROBICIDE
It is an object of the present invention to provide a nanoparticle containing a microbicide and a biodegradable polymer, which is safe and excellent in terms of dispersion stability and has high...
|
|
|
US20090082471 |
DEUTERIUM-ENRICHED FINGOLIMOD
The present application describes deuterium-enriched fingolimod, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
|
|
|
US20090069443 |
Sedative Effect-Imparting Agent And Sedative Perfume Composition Containing The Same
It is intended to provide a sedative effect-imparting agent that provides excellent sedative effect with good fragrance-releasing property, and is possible to provide the excellent sedative effect...
|
|
|
US20090011059 |
Ginger Extract For Inhibiting Human Drug Transporters
The present invention relates to the use of a ginger extract on its own or in combination with pharmaceutical compositions for inhibiting human drug transporters for positively influencing the oral...
|
|
|
US20080207713 |
Compositions and Methods For Enhancing Nitric Oxide Delivery
The present invention is directed to compounds, combinations, compositions and methods for enhancing nitric oxide (NO) delivery to target sites, and in particular to muscle, both normal and...
|
|
|
US20080085892 |
Liquid dosage form of acetaminophen
The present invention relates to a liquid dosage form comprising pharmaceutically insoluble and unpleasant active drug and liquid excipient base. In particular, the invention relates to a liquid...
|
|
|
US20080085312 |
Multi-Phase Release Potassium Guaiacolsulfonate Compositions
Formulations have been developed administering a guaiacolsulfonate salt, preferably potassium salt, in multi-phases. In a preferred embodiment, the formulation contains potassium guaiacolsulfonate...
|
|
|
US20080014252 |
TOPICAL COMPOSITIONS WITH LONG LASTING EFFECT
Topical pharmaceutical formulations and compositions for transdermal delivery of a variety of active agents are described. The formulations and compositions are formulated to provide a long lasting...
|